Brain structure in asymptomatic FMR1 premutation carriers at risk for fragile X-associated tremor/ataxia syndrome

Neurobiology of Aging

Volumn 34, Issue 6, 2013, Pages 1700-1707

  Battistella, Giovanni ^a   Niederhauser, Julien ^a   Fornari, Eleonora ^a   Hippolyte, Loyse ^a   Gronchi Perrin, Aline ^a   Lesca, Gaetan ^b   Forzano, Francesca ^c   Hagmann, Patric ^a   Vingerhoets, Francois J G ^a   Draganski, Bogdan ^a,d,e   Maeder, Philippe ^a   Jacquemont, Sébastien ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c GALLIERA HOSPITAL   (Italy)

^d MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

DTI; FXTAS; Genetics; Premutation; Volumetric MRI

Indexed keywords

ADULT; AGED; ARTICLE; ATAXIA; AUTOMATION; CEREBELLUM; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE CARRIER; DISEASE COURSE; FRAGILE X SYNDROME; GRAY MATTER; HEMISPHERE; HIPPOCAMPAL FIMBRIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBELLAR PEDUNCLE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; WHITE MATTER;

ADULT; AGED; ASYMPTOMATIC DISEASES; ATAXIA; BRAIN; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; SINGLE-BLIND METHOD; TREMOR; YOUNG ADULT;

EID: 84875274487     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.12.001     Document Type: Article

References (46)

1. Anik Y., Iseri P., Demirci A., Komsuoglu S., Inan N. Magnetization transfer ratio in early period of Parkinson disease. Acad. Radiol. 2007, 14:189-192. 10.1016/j.acra.2006.11.005.
2. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113. 10.1016/j.neuroimage.2007.07.007.
3. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851. 10.1016/j.neuroimage.2005.02.018.
4. Bourgeois J.A., Seritan A.L., Casillas E.M., Hessl D., Schneider A., Yang Y., Kaur I., Cogswell J.B., Nguyen D.V., Hagerman R.J. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J. Clin. Psychiatry 2011, 72:175-182. 10.4088/JCP.09m05407blu.
5. Brouwer J.R., Huizer K., Severijnen L.A., Hukema R.K., Berman R.F., Oostra B.A., Willemsen R. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J. Neurochem. 2008, 107:1671-1682. 10.1111/j.1471-4159.2008.05747.x.
6. Brunberg J.A., Jacquemont S., Hagerman R.J., Berry-Kravis E.M., Grigsby J., Leehey M.A., Tassone F., Brown W.T., Greco C.M., Hagerman P.J. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am. J. Neuroradiol. 2002, 23:1757-1766.
7. Chen Y., Tassone F., Berman R.F., Hagerman P.J., Hagerman R.J., Willemsen R., Pessah I.N. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum. Mol. Genet. 2010, 19:196-208. 10.1093/hmg/ddp479.
8. Cornish K.M., Kogan C.S., Li L., Turk J., Jacquemont S., Hagerman R.J. Lifespan changes in working memory in fragile X premutation males. Brain Cogn. 2009, 69:551-558. 10.1016/j.bandc.2008.11.006.
9. Crum R.M., Anthony J.C., Bassett S.S., Folstein M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993, 269:2386-2391.
10. Cunningham C.L., Martinez Cerdeno V., Navarro Porras E., Prakash A.N., Angelastro J.M., Willemsen R., Hagerman P.J., Pessah I.N., Berman R.F., Noctor S.C. Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Hum. Mol. Genet. 2011, 20:64-79. 10.1093/hmg/ddq432.
11. Dousset V., Grossman R.I., Ramer K.N., Schnall M.D., Young L.H., Gonzalez-Scarano F., Lavi E., Cohen J.A. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992, 182:483-491.
12. Draganski B., Ashburner J., Hutton C., Kherif F., Frackowiak R.S., Helms G., Weiskopf N. Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). Neuroimage 2011, 55:1423-1434. 10.1016/j.neuroimage.2011.01.052.
13. Dumas E.M., van den Bogaard S.J., Ruber M.E., Reilman R.R., Stout J.C., Craufurd D., Hicks S.L., Kennard C., Tabrizi S.J., van Buchem M.A., van der Grond J., Roos R.A. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum. Brain Mapp. 2012, 33:203-212. 10.1002/hbm.21205.
14. Fahn S.T., Tolosa E., Marin C. Clinical rating scale for tremor. Parkinson's Disease and Movement Disorders 1993, 271-280. Williams & Wilkins, Baltimore. J. Jankovic, E. Tolosa (Eds.).
15. Fornari E., Knyazeva M.G., Meuli R., Maeder P. Myelination shapes functional activity in the developing brain. Neuroimage 2007, 38:511-518. 10.1016/j.neuroimage.2007.07.010.
16. Fornari E., Maeder P., Meuli R., Ghika J., Knyazeva M.G. Demyelination of superficial white matter in early Alzheimer's disease: a magnetization transfer imaging study. Neurobiol. Aging 2012, 33. 428 e7-19. 10.1016/j.neurobiolaging.2010.11.014.
17. Friston K.J., Tononi G., Reeke G.N., Sporns O., Edelman G.M. Value-dependent selection in the brain: simulation in a synthetic neural model. Neuroscience 1994, 59:229-243.
18. Giulietti G., Bozzali M., Figura V., Spano B., Perri R., Marra C., Lacidogna G., Giubilei F., Caltagirone C., Cercignani M. Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains. Neuroimage 2012, 59:1114-1122. 10.1016/j.neuroimage.2011.09.043.
19. Greco C.M., Berman R.F., Martin R.M., Tassone F., Schwartz P.H., Chang A., Trapp B.D., Iwahashi C., Brunberg J., Grigsby J., Hessl D., Becker E.J., Papazian J., Leehey M.A., Hagerman R.J., Hagerman P.J. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006, 129(Pt 1):243-255. 10.1093/brain/awh683.
20. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., Leehey M., Hagerman P.J. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002, 125(Pt 8):1760-1771.
21. Habas C. [Basic principles of diffusion tensor MR tractography]. J. Radiol. 2004, 85:281-286.
22. Hagmann P., Cammoun L., Gigandet X., Meuli R., Honey C.J., Wedeen V.J., Sporns O. Mapping the structural core of human cerebral cortex. PLoS Biol. 2008, 6:e159. 10.1371/journal.pbio.0060159.
23. Hashimoto R., Javan A.K., Tassone F., Hagerman R.J., Rivera S.M. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain 2011, 134(Pt 3):863-878. 10.1093/brain/awq368.
24. Hashimoto R., Srivastava S., Tassone F., Hagerman R.J., Rivera S.M. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov. Disord. 2011, 26:1329-1336. 10.1002/mds.23646.
25. Hessl D., Tassone F., Loesch D.Z., Berry-Kravis E., Leehey M.A., Gane L.W., Barbato I., Rice C., Gould E., Hall D.A., Grigsby J., Wegelin J.A., Harris S., Lewin F., Weinberg D., Hagerman P.J., Hagerman R.J. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B:115-121. 10.1002/ajmg.b.30241.
26. Jacquemont S., Hagerman R.J., Leehey M., Grigsby J., Zhang L., Brunberg J.A., Greco C., Des Portes V., Jardini T., Levine R., Berry-Kravis E., Brown W.T., Schaeffer S., Kissel J., Tassone F., Hagerman P.J. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 2003, 72:869-878. 10.1086/374321.
27. Jacquemont S., Hagerman R.J., Leehey M.A., Hall D.A., Levine R.A., Brunberg J.A., Zhang L., Jardini T., Gane L.W., Harris S.W., Herman K., Grigsby J., Greco C.M., Berry-Kravis E., Tassone F., Hagerman P.J. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004, 291:460-469. 10.1001/jama.291.4.460 291/4/460.
28. Kloppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., Hicks S.L., Kennard C., Alexander D.C., Parker G.J., Tabrizi S.J., Frackowiak R.S. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131(Pt 1):196-204. 10.1093/brain/awm275.
29. Leehey M.A., Berry-Kravis E., Goetz C.G., Zhang L., Hall D.A., Li L., Rice C.D., Lara R., Cogswell J., Reynolds A., Gane L., Jacquemont S., Tassone F., Grigsby J., Hagerman R.J., Hagerman P.J. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 2008, 70(16 Pt 2):1397-1402. 10.1212/01.wnl.0000281692.98200.f5.
30. Li Y., Jin P. RNA-mediated neurodegeneration in fragile X-associated tremor / ataxia syndrome. Brain Res. 2012, 1462:112-117. http://dx.doi.org/10.1016/j.brainres.2012.02.057.
31. Maes F., Collignon A., Vandermeulen D., Marchal G., Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans. Med. Imaging 1997, 16:187-198. 10.1109/42.563664.
32. Mattis S. Mental Status Examination for Organic Mental Syndrome in the Elderly Patient 1976, Grune and Stratton, New York.
33. Moll N.M., Rietsch A.M., Thomas S., Ransohoff A.J., Lee J.C., Fox R., Chang A., Ransohoff R.M., Fisher E. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann. Neurol. 2011, 70:764-773. 10.1002/ana.22521.
34. Mori S., Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006, 51:527-539. 10.1016/j.neuron.2006.08.012.
35. Nopoulos P.C., Aylward E.H., Ross C.A., Mills J.A., Langbehn D.R., Johnson H.J., Magnotta V.A., Pierson R.K., Beglinger L.J., Nance M.A., Barker R.A., Paulsen J.S. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011, 134(Pt 1):137-142. 10.1093/brain/awq280.
36. Paulsen J.S., Nopoulos P.C., Aylward E., Ross C.A., Johnson H., Magnotta V.A., Juhl A., Pierson R.K., Mills J., Langbehn D., Nance M. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull. 2010, 82:201-207. 10.1016/j.brainresbull.2010.04.003.
37. Pierpaoli C., Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magn. Reson. Med. 1996, 36:893-906.
38. Schoch B., Konczak J., Dimitrova A., Gizewski E.R., Wieland R., Timmann D. Impact of surgery and adjuvant therapy on balance function in children and adolescents with cerebellar tumors. Neuropediatrics 2006, 37:350-358. 10.1055/s-2007-964904.
39. Sevin M., Kutalik Z., Bergman S., Vercelletto M., Renou P., Lamy E., Vingerhoets F.J., Di Virgilio G., Boisseau P., Bezieau S., Pasquier L., Rival J.M., Beckmann J.S., Damier P., Jacquemont S. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J. Med. Genet. 2009, 46:818-824. 10.1136/jmg.2008.065953.
40. Stebbins G.T., Goetz C.G. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section. Mov. Disord. 1998, 13:633-636. 10.1002/mds.870130404.
41. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., Bryer A., Diener H.C., Massaquoi S., Gomez C.M., Coutinho P., Ben Hamida M., Campanella G., Filla A., Schut L., Timann D., Honnorat J., Nighoghossian N., Manyam B. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J. Neurol. Sci. 1997, 145:205-211.
42. van Es A.C., van der Flier W.M., Admiraal-Behloul F., Olofsen H., Bollen E.L., Middelkoop H.A., Weverling-Rijnsburger A.W., Westendorp R.G., van Buchem M.A. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2006, 27:1757-1762. 10.1016/j.neurobiolaging.2005.09.042.
43. Wang J.Y., Hessl D.H., Hagerman R.J., Tassone F., Rivera S.M. Age-dependent structural connectivity effects in fragile x premutation. Arch. Neurol. 2012, 69:482-489. 10.1001/archneurol.2011.2023.
44. Weir D.W., Sturrock A., Leavitt B.R. Development of biomarkers for Huntington's disease. Lancet. Neurol. 2011, 10:573-590. 10.1016/S1474-4422(11)70070-9.
45. Wheeler-Kingshott C.A., Cercignani M. About " axial" and " radial" diffusivities. Magn. Reson. Med. 2009, 61:1255-1260. 10.1002/mrm.21965.
46. Xydis V., Astrakas L., Zikou A., Pantou K., Andronikou S., Argyropoulou M.I. Magnetization transfer ratio in the brain of preterm subjects: age-related changes during the first 2 years of life. Eur. Radiol. 2006, 16:215-220. 10.1007/s00330-005-2796-8.